PHIA Koninklijke Philips N.V.

Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer

Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer

August 18, 2022

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) today convenes an Extraordinary General Meeting of Shareholders (EGM) and publishes the agenda with explanatory note. The sole purpose of the EGM is to appoint Roy Jakobs as the company’s President and Chief Executive Officer, effective October 15, 2022, as successor to Frans van Houten.

The EGM will be held at the Hotel Okura Amsterdam (Ferdinand Bolstraat 333, Amsterdam) on Friday, September 30, 2022, beginning at 09:30 am CET. The agenda with explanatory note and other information relevant for the EGM are available .

For further information, please contact:

Ben Zwirs

Philips Global Press Office

Tel.:

E-mail:

Derya Guzel

Philips Investor Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 79,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
18/08/2022

Underlying

PHIAKoninklijke Philips N.V.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE
Free
PHIA Koninklijke Phi...

Philips launches RADIQAL study to generate real-world evidence for new...

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the USPrimary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the (R...

4h / 25m 1 EN
 PRESS RELEASE
Free
PHIA Koninklijke Phi...

Philips launches real-time 3D intracardiac imaging in Europe, expandin...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – (NYSE: PHG...

May 19, 2025 1 EN
 PRESS RELEASE
Free
PHIA Koninklijke Phi...

Philips successfully prices offering of Notes for EUR 1 billion to be ...

Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects May 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any ...

May 15, 2025 1 EN
 PRESS RELEASE
Free
PHIA Koninklijke Phi...

Philips Future Health Index 2025: AI poised to transform global health...

Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. H...

May 15, 2025 1 EN
Free Trial
PHIA Koninklijke Phi...

Koninklijke Philips N.V.: 1 director

A director at Koninklijke Philips N.V. bought 8,176 shares at 24.410USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

PHIA KONINKLIJKE PHILIPS N.V.
05/14/25 May 14, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch